Evidence map›Paper›PMID 38259673›Full record

ArticleJournal of cancer & allied specialties2024

A Longitudinal Metagenomic Comparative Analysis of Oral Microbiome Shifts in Patients Receiving Proton Radiation versus Photon Radiation for Head and Neck Cancer.

Timothy F Meiller, Claire M Fraser, Silvia Grant-Beurmann, Mike Humphrys, Luke Tallon, Lisa D Sadzewicz, Mary Ann Jabra-Rizk, Areej Alfaifi, Anmar Kensara, Jason K Molitoris and 6 more

Open access · diamondAbstract read
In one paragraph

Article in Journal of cancer & allied specialties, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Timothy F MeillerDepartment of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, United States.
Claire M FraserDepartment of Medicine, University of Maryland School of Medicine, Baltimore, United States.
Silvia Grant-BeurmannInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, United States.
Mike HumphrysInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, United States.
Luke TallonInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, United States.
Lisa D SadzewiczInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, United States.
Mary Ann Jabra-RizkDepartment of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, United States.
Areej AlfaifiDepartment of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, United States.
Anmar KensaraDepartment of Advanced Oral Sciences and Therapeutics, School of Dentistry, University of Maryland, Baltimore, United States.
Jason K MolitorisUniversity of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, United States.
Matthew WitekUniversity of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, United States.
William S MendesDepartment of Radiation Oncology, University of Maryland Medical Center, Baltimore, United States.
William F RegineUniversity of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, United States.
Phuoc T TranDepartment of Radiation Oncology, University of Maryland Medical Center, Baltimore, United States.
Robert C MillerDepartment of Radiation Medicine, University of Kentucky College of Medicine, Lexington, United States.
Ahmed S SultanDepartment of Oncology and Diagnostic Sciences, School of Dentistry, University of Maryland, Baltimore, United States.
University of Maryland, Baltimore · USUniversity of Maryland Medical Center · USUniversity of Kentucky · USUniversity of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Due to the radiation-sparing effects on salivary gland acini, changes in the composition of the oral microbiome may be a driver for improved outcomes in patients receiving proton radiation, with potentially worse outcomes in patients exposed to photon radiation therapy. To date, a head-to-head comparison of oral microbiome changes at a metagenomic level with longitudinal sampling has yet to be performed in these patient cohorts. Methods and Materials: To comparatively analyze oral microbiome shifts during head and neck radiation therapy, a prospective pilot cohort study was performed at the Maryland Proton Treatment Center and the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center. A longitudinal metagenomic comparative analysis of oral microbiome shifts was performed at three time points (pre-radiation, during radiation, and immediately post-radiation). Head and neck cancer patients receiving proton radiation ( Results: Photon therapy patients presented with lower microbial alpha diversity at all timepoints, and there was a trend towards reduced species richness as compared with proton therapy. Healthy controls and proton patients exhibited overall higher and similar diversity. A more dysbiotic state was observed in patients receiving photon therapy as compared to proton therapy, in which oral microbial homeostasis was maintained. Mucositis was observed in 3/4 photon patients and was not observed in any proton patients during radiation therapy. The bacterial de novo pyrimidine biosynthesis pathway and the nitrate reduction V pathway were comparatively higher following photon exposure. These functional changes in bacterial metabolism may suggest that photon exposure produces a more permissive environment for the proliferation of pathogenic bacteria. Conclusion: Oral microbiome dysbiosis in patients receiving photon radiation may be associated with increased mucositis occurrence. Proton radiation therapy for head and neck cancer demonstrates a safer side effect profile in terms of oral complications, oral microbiome dysbiosis, and functional metabolic status.

Indexed as

Head and Neck Cancermetagenomeoral microbiomeradiation therapy

Identifiers

PMID38259673
PMCPMC10793722
OpenAlexW4391127605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.